Calumet stock reaches 52-week high at $45.20

Calumet Inc's stock has reached a new 52-week high, trading at $45.32, marking a 237.98% increase over the past year. The stock is currently valued above its fair price, placing it among overvalued equities according to InvestingPro data. Despite the stock's high valuation, strong investor confidence and positive market conditions contribute to the company's notable achievement.

Although Calumet was not profitable over the previous year, analysts expect profitability this year. Investors may find further details in the comprehensive Pro Research Report, which provides expert analysis on CLMT alongside 1,400+ other US equities. Calumet reported mixed financial results for the second quarter of 2026, surpassing revenue estimates but missing earnings forecasts.

The company achieved $1.44 billion in revenue, generating $175 million in adjusted EBITDA and over $90 million in operating cash flow. Despite the earnings miss, strong pricing and execution across the business contributed to the revenue increase. Investors remain closely monitoring Calumet's financial performance as market reactions to the earnings disparity continue to unfold.